WEP Clinical (WEP), a clinical services company that works with pharmaceutical companies to help patients and physicians gain access to medicines when treatment options are limited or unavailable, has partnered with Plusultra pharma (PUP) [...]
WEP Clinical (WEP) is pleased to announce a partnership with Geron Corporation (Geron), a late-stage clinical biopharmaceutical company, to make investigational drug, imetelstat, available to patients through an Expanded Access Protocol (EAP). EAPs offer [...]
WEP Clinical LTD (WEP), a specialist services company that works with pharmaceutical companies to help patients and physicians gain access to medicines when no other treatment options are available, has partnered with Theratechnologies Inc. [...]
WEP Clinical LTD (WEP), a specialist services company that works with drug developers to help patients and physicians gain early access to medicines when no other treatment options are available, has partnered with biopharmaceutical [...]
WEP Clinical LTD (WEP), a specialist services company that works with drug developers to help patients and physicians gain early access to medicines when no other treatment options are available, has partnered with biopharmaceutical [...]
WEP Clinical (WEP) is pleased to announce a new partnership with Y-mAbs Therapeutics, Inc. (Y-mAbs), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. [...]
WEP Clinical LTD (WEP), a specialist services company that works with pharmaceutical companies to help patients and physicians gain access to medicines when no other treatment options are available, has partnered with TaiMed Biologics [...]